Guggulsterone and bexarotene induce secretion of exosome‐associated breast cancer resistance protein and reduce doxorubicin resistance in MDA‐MB‐231 cells

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Cancer

• Publication date

  2015-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.29542PMID 25833198PMCID PMC4503537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extracellular vesicles as modulators of the cancer microenvironment.

  2015cited by this paper
• Cellular communication via microparticles: role in transfer of multidrug resistance in cancer.

  2014cited by this paper
• ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.

  2014cited by this paper
• Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.

  2014influential reference
• The network of P‐glycoprotein and microRNAs interactions

  2014cited by this paper
• Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma.

  2014cited by this paper
• Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions.

  2014cited by this paper
• IMP3 Protein Promotes Chemoresistance in Breast Cancer Cells by Regulating Breast Cancer Resistance Protein (ABCG2) Expression*

  2013influential reference
• Exosomes in tumor microenvironment influence cancer progression and metastasis

  2013cited by this paper
• Breast cancer stem cells: an update

  2013cited by this paper
• Breast cancer stem cells: a novel therapeutic target.

  2013cited by this paper
• Breast Cancer-Derived Microparticles Display Tissue Selectivity in the Transfer of Resistance Proteins to Cells

  2013cited by this paper
• Extracellular vesicles: biology and emerging therapeutic opportunities

  2013cited by this paper
• Breast cancer resistance protein(BCRP/ABCG2):its role in multidrug resistance and regulation of its gene expression

  2012cited by this paper
• Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-β by Microglia

  2012cited by this paper
• Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

  2012cited by this paper
• Reversion of P-glycoprotein-mediated multidrug resistance by guggulsterone in multidrug-resistant human cancer cell lines.

  2012cited by this paper
• Microparticles and their emerging role in cancer multidrug resistance.

  2012cited by this paper
• Differential regulation of acid sphingomyelinase in macrophages stimulated with oxidized low‐density lipoprotein (LDL) and oxidized LDL immune complexes: role in phagocytosis and cytokine release

  2012cited by this paper
• ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

  2012cited by this paper
• Breast cancer, side population cells and ABCG2 expression.

  2012cited by this paper
• Astrocytes Secrete Exosomes Enriched with Proapoptotic Ceramide and Prostate Apoptosis Response 4 (PAR-4)

  2012cited by this paper
• The gut-to-breast connection - interdependence of sterols and sphingolipids in multidrug resistance and breast cancer therapy.

  2011cited by this paper
• Functional interrelationship between the WASF3 and KISS1 metastasis‐associated genes in breast cancer cells

  2011cited by this paper
• Structure and Function of ABCG2-Rich Extracellular Vesicles Mediating Multidrug Resistance

  2011cited by this paper
• Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation

  2010cited by this paper
• Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

  2010cited by this paper
• Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells

  2009cited by this paper
• Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer

  2009cited by this paper
• High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability

  2009cited by this paper
• Disruption of N‐linked glycosylation enhances ubiquitin‐mediated proteasomal degradation of the human ATP‐binding cassette transporter ABCG2

  2009cited by this paper
• Cancer stem cells: how can we target them?

  2008cited by this paper
• Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes

  2008influential reference
• Targeting vesicle trafficking: an important approach to cancer chemotherapy.

  2008cited by this paper
• Side population cells in human cancers.

  2008cited by this paper
• Quantitation of Doxorubicin Uptake, Efflux, and Modulation of Multidrug Resistance (MDR) in MDR Human Cancer Cells

  2008cited by this paper
• Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide

  2008influential reference
• The guggul for chronic diseases: ancient medicine, modern targets.

  2008cited by this paper
• Breast cancer stem cells: implications for therapy of breast cancer

  2008cited by this paper
• Bile acids and derivatives, their nuclear receptors FXR, PXR and ligands: role in health and disease and their therapeutic potential.

  2008cited by this paper
• Development and characterization of a novel anti-ceramide antibody Published, JLR Papers in Press, January 8, 2007.

  2007cited by this paper
• Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells.

  2007cited by this paper
• Identification of side population cells (stem-like cell population) in pediatric solid tumor cell lines.

  2007cited by this paper
• Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas

  2007cited by this paper
• The ATP-binding Cassette Transporter ABCG2 (BCRP), a Marker for Side Population Stem Cells, Is Expressed in Human Heart

  2006cited by this paper
• Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.

  2006cited by this paper
• Lipids isolated from bone induce the migration of human breast cancer cells Published, JLR Papers in Press, January 26, 2006.

  2006cited by this paper
• Guggulsterones induce apoptosis and differentiation in acute myeloid leukemia: identification of isomer-specific antileukemic activities of the pregnadienedione structure

  2005cited by this paper
• The selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced breast carcinoma

  2005cited by this paper
• MS-209 Schering.

  2004cited by this paper
• Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

  2003cited by this paper
• Increase of ceramide in adriamycin-induced HL-60 cell apoptosis: detection by a novel anti-ceramide antibody.

  2002cited by this paper
• Multivesicular Bodies and Multivesicular Endosomes: The "Ins and Outs" of Endosomal Traffic

  2002cited by this paper
• Ligand-Dependent Degradation of Retinoid X Receptors Does Not Require Transcriptional Activity or Coactivator Interactions

  2001cited by this paper

• The Role of Exosomes as a Key Factor of Cytostatic Resistance in Cancer: Mechanisms of Action, Potential Biomarkers, and Possible Exosome-Based Therapies

  2025cites this paper
• The Multifaceted Nature of Guggulsterone: Phytochemical Insights and Pharmacological Efficacy

  2025cites this paper
• Breast cancer cell-derived extracellular vesicles accelerate collagen fibrillogenesis and integrate into the matrix

  2025cites this paper
• The Role of The Xihuang Pill in Inhibiting Triple-Negative Breast Cancer Through Immunogenic Cell Death

  2025cites this paper
• Organotin(IV) carboxylates—derivatives of bexarotene: synthesis, characterization, anti/prooxidant activity, and high cytotoxicity

  2025cites this paper
• Nuclear receptors in cancer: Unveiling theranostic potentials and innovative therapeutic strategies.

  2025cites this paper
• Exosome-Mediated Chemoresistance in Cancers: Mechanisms, Therapeutic Implications, and Future Directions

  2025cites this paper
• Exosome-Mediated Cellular Communication in the Tumor Microenvironment Imparts Drug Resistance in Breast Cancer

  2025cites this paper
• Extracellular Vesicles as Mediators and Potential Targets in Combating Cancer Drug Resistance

  2025cites this paper
• Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP)

  2024cites this paper
• A Narrative Overview of Retinoid X Receptor Inhibitors in Chronic Disease Management.

  2024cites this paper
• Synergistic Activation of VDR-RXR Heterodimers by Vitamin D and Rexinoids in Human Kidney and Brain Cells

  2024cites this paper
• Lipid metabolism involved in progression and drug resistance of breast cancer

  2024cites this paper
• Extracellular Vesicle Mobility in Collagen I Hydrogels Is Influenced by Matrix-Binding Integrins

  2024cites this paper
• Research progress of exosomes in drug resistance of breast cancer

  2024cites this paper
• The promising roles of exosomal microRNAs in osteosarcoma: A new insight into the clinical therapy.

  2023cites this paper
• Current stage of preclinical and clinical development of guggulsterone in cancers: Challenges and promises

  2023cites this paper
• Machine learning-based analysis of cancer cell-derived vesicular proteins revealed significant tumor-specificity and predictive potential of extracellular vesicles for cell invasion and proliferation – A meta-analysis

  2023cites this paper
• Exosomes in Cancer Progression and Therapy Resistance: Molecular Insights and Therapeutic Opportunities

  2023cites this paper
• Exposure to anticancer drugs modulates the expression of ACSL4 and ABCG2 proteins in adrenocortical carcinoma cells

  2023cites this paper
• Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming.

  2023cites this paper
• Extracellular Vesicles and Cancer Multidrug Resistance: Undesirable Intercellular Messengers?

  2023cites this paper
• MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells

  2023cites this paper
• Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment

  2022cites this paper
• Extracellular vesicles as a novel approach for breast cancer therapeutics.

  2022cites this paper
• Natural compounds targeting nuclear receptors for effective cancer therapy

  2022cites this paper
• Baicalein sensitizes triple negative breast cancer MDA-MB-231 cells to doxorubicin via autophagy-mediated down-regulation of CDK1

  2022cites this paper
• Multifunctional Role of Lipids in Modulating the Tumorigenic Properties of 4T1 Breast Cancer Cells

  2022cites this paper
• Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases.

  2021cites this paper
• Extracellular vesicle-mediated transport: Reprogramming a tumor microenvironment conducive with breast cancer progression and metastasis

  2021cites this paper
• Impact of native and external factors on exosome release: understanding reactive exosome secretion and its biogenesis

  2021cites this paper
• Exosomes: A Forthcoming Era of Breast Cancer Therapeutics

  2021cites this paper
• Physiological functions and therapeutic applications of neutral sphingomyelinase and acid sphingomyelinase.

  2021cites this paper
• Extracellular Vesicles in Chemoresistance.

  2021cites this paper
• Recent advances in novel drug delivery systems and approaches for management of breast cancer: A comprehensive review

  2020cites this paper
• Molecular avenues in targeted doxorubicin cancer therapy.

  2020cites this paper
• The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance

  2020cites this paper
• Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions

  2020cites this paper
• Phytonanomedicine: a novel avenue to treat recurrent cancer by targeting cancer stem cells.

  2020cites this paper
• Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives.

  2020cites this paper
• Exosomes and breast cancer drug resistance

  2020cites this paper
• Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer

  2020influential citation
• The juxtamembrane linker in neutral sphingomyelinase-2 functions as an intramolecular allosteric switch that activates the enzyme

  2019cites this paper
• Plant and Human Health, Volume 3

  2019cites this paper
• Exosomes: A Promising Avenue for the Diagnosis of Breast Cancer

  2019cites this paper
• Tumor-derived extracellular vesicles in breast cancer: from bench to bedside.

  2019cites this paper
• Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy

  2019cites this paper
• Chemistry and Pharmacology of Guggulsterone: An Active Principle of Guggul Plant

  2019cites this paper
• Acyl‐CoA synthetase‐4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy‐dependent transporter expression

  2019cites this paper
• Inhibiting exosomal MIC-A and MIC-B shedding of cancer cells to overcome immune escape: new insight of approved drugs

  2019cites this paper
• Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases

  2018cites this paper
• Increased liver tumor formation in neutral sphingomyelinase-2-deficient mice

  2018cites this paper
• Exosome-Based Cell-Cell Communication in the Tumor Microenvironment

  2018cites this paper
• Exploring the Therapeutic Landscape of Sphingomyelinases.

  2018cites this paper
• Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer

  2018cites this paper
• Sphingolipids and lipid rafts: Novel concepts and methods of analysis.

  2018cites this paper
• Neutral Sphingomyelinases in Cancer: Friend or Foe?

  2018cites this paper
• Ceramide and Exosomes: A Novel Target in Cancer Biology and Therapy: CHAPTER FIVE

  2018cites this paper
• The Onus of Sphingolipid Enzymes in Cancer Drug Resistance.

  2018cites this paper
• Extracellular vesicles and anti-cancer drug resistance.

  2018cites this paper
• Modifying exosome release in cancer therapy: How can it help?

  2018cites this paper
• Exosomes in cancer: small vesicular transporters for cancer progression and metastasis, biomarkers in cancer therapeutics

  2018cites this paper
• SIRT 5 as a biomarker for response to anthracycline-taxane-based neoadjuvant chemotherapy in triple-negative breast cancer

  2018cites this paper
• Oncogenic Extracellular Vesicle Biogenesis and Protein Trafficking

  2017cites this paper
• Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner

  2017cites this paper
• Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivo

  2017cites this paper
• Potential therapeutic targets of Guggulsterone in cancer

  2017cites this paper
• Morphogenetic Sphingolipids in Stem Cell Differentiation and Embryo Development

  2017cites this paper
• Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer.

  2017cites this paper
• Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity.

  2017cites this paper
• Effect of Bexarotene on Platelet Activation and Apoptosis

  2017cites this paper
• Mechanisms of Drug Resistance in Cancer: The Role of Extracellular Vesicles

  2017cites this paper
• The ceramide pathway is involved in the survival, apoptosis and exosome functions of human multiple myeloma cells in vitro

  2017cites this paper
• Landscaping the cell surface proteome of breast cancer: Following pathways through organelles to the plasma membrane

  2017cites this paper
• Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro

  2016cites this paper
• Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.

  2016cites this paper
• Triggering of Suicidal Erythrocyte Death by Bexarotene

  2016cites this paper
• Mechanisms of tumor cell resistance to the current targeted-therapy agents

  2016cites this paper
• Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment

  2016cites this paper
• Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers

  2016cites this paper
• Guggulsterone for Chemoprevention of Cancer.

  2015cites this paper
• Intercellular Transfer of Cancer Drug Resistance Traits by Extracellular Vesicles.

  2015cites this paper
• The role and relevance of exosomes in the development and progression of prostate cancer

  2015cites this paper
• The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate Cancer

  2015cites this paper